Effects of enamel matrix derivative on clinical and inflammatory outcomes in periodontal maintenance patients: Randomized controlled clinical trial

被引:4
作者
Jasa, Erica E. [1 ]
Gradoville, Jessica M. [1 ]
Christiansen, Mary M. [1 ]
Samson, Kaeli K. [2 ]
Reinhardt, Richard A. [1 ]
Payne, Jeffrey B. [1 ]
Killeen, Amy C. [1 ]
机构
[1] Univ Nebraska Med Ctr, Coll Dent, Dept Surg Specialties, Lincoln, NE USA
[2] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE USA
关键词
chronic periodontitis; enamel matrix proteins; interleukin-1beta; ALVEOLAR-TYPE DEFECTS; ACCESS FLAP SURGERY; INTRABONY DEFECTS; SYSTEMIC ANTIBIOTICS; PROTEINS; EMDOGAIN(R); ATTACHMENT; ADJUNCTS;
D O I
10.1002/JPER.19-0623
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background Efficient methods to treat persistent pockets during periodontal maintenance therapy (PMT) require further investigation. The hypothesis of this randomized controlled clinical trial was that local application of enamel matrix derivative (EMD) added to papilla reflection/root preparation (PR/RP) could enhance clinical and inflammatory outcomes, primarily clinical attachment level (CAL). Methods Fifty PMT patients with generalized stage III-IV, grade B periodontitis presenting with a 6- to 9-mm interproximal PD were randomly allocated to (PR/RP+EMD; n = 24) and control (PR/RP+saline; n = 26) therapies by sex and smoking status. Roots were treated with reflection of interproximal papillae, root planing assisted with endoscope evaluation, and acid etching, followed by EMD or saline application. Probing depth (PD), CAL, plaque index (PI), and interproximal bone height were evaluated at baseline and 12-months post-therapy. Gingival crevicular fluid, bleeding on probing (BOP), and interleukin-1 beta were tested (ELISA) at baseline, 2 weeks, and 6 and 12 months. Groups were compared over time and between groups with Wilcoxon Rank Sum and t-tests. Results Both PR/RP+ EMD and PR/RP+S resulted in significant improvements in clinical outcomes (PD and CAL, BOP) from baseline to 12 months. No significant differences were found in clinical or inflammatory outcomes between the experimental and control groups. Conclusions The addition of EMD to PR/RP does not significantly improve clinical or inflammatory outcomes compared with PR/RP alone during periodontal maintenance therapy.
引用
收藏
页码:1400 / 1408
页数:9
相关论文
共 50 条
[41]   Clinical evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans [J].
Sculean, A ;
Barbé, G ;
Chiantella, GC ;
Arweiler, NB ;
Berakdar, M ;
Brecx, M .
JOURNAL OF PERIODONTOLOGY, 2002, 73 (04) :401-408
[42]   Evaluation of Recombinant Human Platelet-Derived Growth Factor or Enamel Matrix Derivative Plus Calcium Hydroxide for Pulp Capping: A Randomized Controlled Human Clinical Trial [J].
Al-Hezaimi, Khalid ;
Naghshbandi, Jafar ;
Alhuzaimi, Raed ;
Alonaizan, Faisal ;
AlQwizany, Ibrahim ;
Rotstein, Ilan .
INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY, 2020, 40 (05) :645-654
[43]   Evaluation of gingival crevicular fluid transforming growth factor-1 level after treatment of intrabony periodontal defects with enamel matrix derivatives and autogenous bone graft: A randomized controlled clinical trial [J].
Agrali, O. B. ;
Kuru, B. E. ;
Yarat, A. ;
Kuru, L. .
NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2016, 19 (04) :535-543
[44]   A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal class II furcation involvement in mandibular molars.: Part II:: Secondary outcomes [J].
Meyle, J ;
Gonzales, JR ;
Bödeker, RH ;
Hoffmann, T ;
Richter, S ;
Heinz, B ;
Arjomand, M ;
Reich, E ;
Sculean, A ;
Jepsen, K ;
Jepsen, S .
JOURNAL OF PERIODONTOLOGY, 2004, 75 (09) :1188-1195
[45]   Clinical effects of nanocrystalline hydroxyapatite paste in the treatment of intrabony periodontal defects: a randomized controlled clinical study [J].
Bernd Heinz ;
Adrian Kasaj ;
Marie Teich ;
Søren Jepsen .
Clinical Oral Investigations, 2010, 14 :525-531
[46]   Radiographic angle width as predictor of clinical outcomes following regenerative periodontal therapy with enamel matrix derivative: a retrospective cohort study with a mean follow-up of at least 10 years [J].
Roccuzzo, Andrea ;
Ettmayer, Johanna ;
De Ry, Siro Pietro ;
Imber, Jean-Claude ;
Sculean, Anton ;
Salvi, Giovanni Edoardo .
QUINTESSENCE INTERNATIONAL, 2023, 54 (05) :384-392
[47]   Partial pulpotomy on caries-free teeth using enamel matrix derivative or calcium hydroxide: a randomized controlled trial [J].
Kiatwateeratana, T. ;
Kintarak, S. ;
Piwat, S. ;
Chankanka, O. ;
Kamaolmatyakul, S. ;
Thearmontree, A. .
INTERNATIONAL ENDODONTIC JOURNAL, 2009, 42 (07) :584-592
[48]   Treatment of Non-Contained Infrabony Defects With Enamel Matrix Derivative Alone or in Combination With Biphasic Calcium Phosphate Bone Graft: A 12-Month Randomized Controlled Clinical Trial [J].
Losada, Meritxell ;
Gonzalez, Rodrigo ;
Pujol Garcia, Angels ;
Santos, Antonio ;
Nart, Jose .
JOURNAL OF PERIODONTOLOGY, 2017, 88 (05) :426-435
[49]   Gingival recession treatment with enamel matrix derivative associated with coronally advanced flap and subepithelial connective tissue graft: a split-mouth randomized controlled clinical trial with molecular evaluation [J].
Dias, Alexandra Tavares ;
de Menezes, Claudia Callegaro ;
Kahn, Sergio ;
Fischer, Ricardo Guimaraes ;
da Silva Figueredo, Carlos Marcelo ;
de Oliveira Fernandes, Gustavo Vicentis .
CLINICAL ORAL INVESTIGATIONS, 2022, 26 (02) :1453-1463
[50]   Clinical evaluation of the Er:YAG laser in combination with an enamel matrix protein derivative for the treatment of intrabony periodontal defects:: a pilot study [J].
Schwarz, F ;
Sculean, A ;
Georg, T ;
Becker, J .
JOURNAL OF CLINICAL PERIODONTOLOGY, 2003, 30 (11) :975-981